Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease

Author

Sánchez Danés, Adriana

Richaud-Patin, Yvonne

Carballo Carbajal, Iria

Jiménez Delgado, Senda

Caig, Carles

Mora, Sergio

Di Guglielmo, Claudia

Ezquerra Trabalón, Mario

Patel, Bindiben

Giralt Torroella, Albert

Canals i Coll, Josep M.

Memo, Maurizio

Alberch i Vié, Jordi, 1959-

López Barneo, José

Vila Farré, Miquel

Cuervo, Ana Maria

Tolosa, Eduardo

Consiglio, Antonella

Raya Chamorro, Ángel

Publication date

2019-05-24T16:19:00Z

2019-05-24T16:19:00Z

2012-05

2019-05-24T16:19:00Z

Abstract

Induced pluripotent stem cells (iPSC) offer an unprecedented opportunity to model human disease in relevant cell types, but it is unclear whether they could successfully model age-related diseases such as Parkinson's disease (PD). Here, we generated iPSC lines from seven patients with idiopathic PD (ID-PD), four patients with familial PD associated to the G2019S mutation in the Leucine-Rich Repeat Kinase 2 (LRRK2) gene (LRRK2-PD) and four age- and sex-matched healthy individuals (Ctrl). Over long-time culture, dopaminergic neurons (DAn) differentiated from either ID-PD- or LRRK2-PD-iPSC showed morphological alterations, including reduced numbers of neurites and neurite arborization, as well as accumulation of autophagic vacuoles, which were not evident in DAn differentiated from Ctrl-iPSC. Further induction of autophagy and/or inhibition of lysosomal proteolysis greatly exacerbated the DAn morphological alterations, indicating autophagic compromise in DAn from ID-PD- and LRRK2-PD-iPSC, which we demonstrate occurs at the level of autophagosome clearance. Our study provides an iPSC-based in vitro model that captures the patients' genetic complexity and allows investigation of the pathogenesis of both sporadic and familial PD cases in a disease-relevant cell type.

Document Type

Article
Published version

Language

English

Subjects and keywords

Dopamina; Metabolisme; Fenotip; Genètica; Neurones; Malaltia de Parkinson; Patologia; Cèl·lules mare; Dopamine; Metabolism; Phenotype; Genetics; Neurons; Parkinson's disease; Pathology; Stem cells

Publisher

EMBO Press

Related items

Reproducció del document publicat a: https://doi.org/10.1002/emmm.201200215

EMBO Molecular Medicine, 2012, vol. 4, num. 5, p. 380-395

https://doi.org/10.1002/emmm.201200215

Rights

(c) EMBO, 2012